Farah coach used prohibited drug infusions, says newspaper | Reuters

Britain’s Olympic champion Mo Farah’s coach has been accused of using prohibited drug infusions to improve the performance of his runners, the Sunday Times reported citing a leaked United States Anti-Doping Agency (USADA) report.

The newspaper said the 2016 report also accused coach Alberto Salazar of abusing prescription medicines for his athletes at the Nike training center in Oregon.

Attempts by Reuters to reach Salazar for comment were unsuccessful. Salazar issued a lengthy and detailed denial of similar allegations in 2015.

The Sunday Times said the report had been leaked by the ‘Fancy Bears’ hacking group which has previously leaked medical and doping-related documents.

USADA on Saturday confirmed to Reuters the documented cited by the Sunday Times appeared to have been leaked but would not comment on the report’s conclusions or any accusations against Salazar.

“USADA can confirm that it has prepared a report in response to a subpoena from a state medical licensing body regarding care given by a physician to athletes associated with the Nike Oregon Project,” USADA Communications Manager Ryan Madden said in an email to Reuters.

“It appears that a draft of this report was leaked to the Sunday Times by the Russian state-affiliated hacker group known as Fancy Bears.

“We understand that the licensing body is still deciding its case and as we continue to investigate whether anti-doping rules were broken, no further comment will be made at this time.”

The Sunday Times said that Farah and other athletes coached by Salazar were given infusions of a research supplement based on the chemical L-carnitine and that one coach who was given a high dosage said that it was as effective as illegal blood doping, according to the report.

It said Salazar also emailed disgraced cyclist Lance Armstrong touting the benefits of L-carnitine.

Salazar, a Cuban-born American marathoner who has worked with Farah since 2011, was accused of violating anti-doping…

Read the full article from the Source…

Leave a Reply

Your email address will not be published. Required fields are marked *